Featured Chrome Extensions:

Casey IRACs are produced by an AI that analyzes the opinion’s content to construct its analysis. While we strive for accuracy, the output may not be flawless. For a complete and precise understanding, please refer to the linked opinions above.

Keywords

negligenceliabilitystrict liabilitycommon law
negligenceliabilitystrict liability

Related Cases

In re Collins, 286 S.W.3d 911, 52 Tex. Sup. Ct. J. 813
View Case »
Providence Health Center v. Dowell, 262 S.W.3d 324, 51 Tex. Sup. Ct. J. 935
View Case »
Spencer v. Goodill, 17 A.3d 552
View Case »
Olson v. Molzen, 558 S.W.2d 429
View Case »
Doe v. Guthrie Clinic, Ltd., 22 N.Y.3d 480, 5 N.E.3d 578, 982 N.Y.S.2d 431, 2014 N.Y. Slip Op. 00138
View Case »
Justia Law Link
LexisNexis Link
Westlaw Link
CourtListener Link
Oyez Link

Riegel v. Medtronic, Inc., 552 U.S. 312, 128 S.Ct. 999, 169 L.Ed.2d 892, 76 USLW 4087, Prod.Liab.Rep. (CCH) P 17,924, 08 Cal. Daily Op. Serv. 2105, 2008 Daily Journal D.A.R. 2524, 21 Fla. L. Weekly Fed. S 81

Facts

Charles Riegel, a cardiac patient, underwent an angioplasty in 1996 using a Medtronic Evergreen Balloon Catheter, a Class III medical device that had received FDA premarket approval. During the procedure, the catheter ruptured after being inflated beyond its rated pressure, resulting in severe complications for Riegel. He and his wife subsequently sued Medtronic, alleging that the catheter was defectively designed and labeled, violating New York common law. The District Court ruled that the Medical Device Amendments preempted their claims, a decision that was upheld by the Second Circuit.

Charles Riegel, a cardiac patient, underwent an angioplasty in 1996 using a Medtronic Evergreen Balloon Catheter, a Class III medical device that had received FDA premarket approval.

Issue

Whether the Medical Device Amendments of 1976 preempt state-law claims of negligence, strict liability, and implied warranty against manufacturers of medical devices that have received premarket approval from the FDA.

Whether the Medical Device Amendments of 1976 preempt state-law claims of negligence, strict liability, and implied warranty against manufacturers of medical devices that have received premarket approval from the FDA.

Rule

The Medical Device Amendments of 1976 establish that no state may impose requirements that are different from or in addition to federal requirements applicable to medical devices, particularly those that relate to safety and effectiveness.

The Medical Device Amendments of 1976 establish that no state may impose requirements that are different from or in addition to federal requirements applicable to medical devices, particularly those that relate to safety and effectiveness.

Analysis

The Court analyzed the preemption clause of the Medical Device Amendments, determining that the FDA's premarket approval process imposes specific federal requirements on medical devices. The Court concluded that the Riegels' common-law claims imposed state requirements that were different from the federal standards, thus falling under the preemption clause. The Court emphasized that allowing state claims would disrupt the federal regulatory scheme designed to ensure the safety and effectiveness of medical devices.

The Court analyzed the preemption clause of the Medical Device Amendments, determining that the FDA's premarket approval process imposes specific federal requirements on medical devices.

Conclusion

The Supreme Court affirmed the lower court's ruling, holding that the Riegels' state-law claims were preempted by the federal requirements established by the FDA for the Medtronic catheter.

The Supreme Court affirmed the lower court's ruling, holding that the Riegels' state-law claims were preempted by the federal requirements established by the FDA for the Medtronic catheter.

Who won?

Medtronic prevailed in the case because the Supreme Court found that the federal preemption clause of the Medical Device Amendments barred the Riegels' state-law claims, which would impose additional requirements on the manufacturer beyond those mandated by federal law.

Medtronic prevailed in the case because the Supreme Court found that the federal preemption clause of the Medical Device Amendments barred the Riegels' state-law claims.

You must be